StonvexLoading…
StonvexStonvexStonvexCore line items from CPHI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $4.14M | $4.53M | $7.01M | $8.10M |
Operating Income | $-3.24M | $-4.59M | $-2.75M | $-3.55M |
Net Income | $-3.19M | $-4.74M | $-3.08M | $-3.97M |
EPS (Diluted) | $-0.74 | $-2.71 | $-0.91 | $-3.78 |
Total Assets | $31.00M | $14.89M | $16.47M | $17.78M |
Total Liabilities | $8.26M | $7.14M | $9.01M | $13.49M |
Cash & Equivalents | $345.11K | $626.88K | $1.42M | $2.03M |
Free Cash Flow OCF − CapEx | $88.94K | $-444.47K | $-711.20K | $-811.51K |
Shares Outstanding | 15.52M | 3.26M | 10.63M | 1.50M |